Research Article

Inverse Relationship of the CMKLR1 Relative Expression and Chemerin Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin Resistance

Table 2

Correlation of chemerin and insulin serum levels with the dysmetabolic phenotype and body fat adiposity markers status in the study groups.

Measurements Chemerin (ng/mL)Insulin (UI/mL)
Correlation (%)

Body weight (kg)−2.8
BMI (kg/m2)15.3
Body fat mass (%)
Total body fat mass (kg)
Waist circumference (cm)
Hip circumference (cm)
Waist-hip ratio 5.8
Body fat ratio
Waist to height ratio
Conicity index
Coronal abdominal diameter (cm)8.4
Sagittal abdominal diameter (cm)15.7
Total adipose area (cm2)
Visceral area (cm2)
Subcutaneous abdominal area (cm2)17.6
Glucose (mg/dL)−6.3
Skinfold thickness (mm):
 Abdominal−10.3
 Bicipital
 Tricipital
 Subscapular11.1
 Suprailiac
Triglycerides (mg/dL)
LDLc (mg/dL)13.0
VLDLc (mg/dL)
HDLc (mg/dL)10.1
NEFA (mmol/L)9.0
CRP (mg/L)14.1
ESR (mm/h)1.8

IR: insulin resistance. HDLc, LDLc, and VLDLc (lipoproteins of high, low, and very low density cholesterol, resp.); NEFA: nonesterified fatty acids; CRP: C reactive protein; ESR: erythrocyte sedimentation rate. < 0.001, P < 0.05, Pearson correlation test.